ADMA Biologics Inc (ADMA)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 88,942 | 35,265 | 1,173 | -19,072 | -10,155 |
| Revenue | US$ in thousands | 258,215 | 154,080 | 80,943 | 42,220 | 29,349 |
| Gross profit margin | 34.44% | 22.89% | 1.45% | -45.17% | -34.60% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $88,942K ÷ $258,215K
= 34.44%
ADMA Biologics Inc has shown significant fluctuations in its gross profit margin over the past five years. The company experienced a substantial improvement in its gross profit margin from 2019 to 2023, increasing from -34.60% to 34.44%. This indicates that the company has been able to effectively manage its cost of goods sold and improve its pricing strategies to increase profitability.
The positive trend in the gross profit margin signifies that ADMA Biologics Inc has been successful in optimizing its production and operational efficiencies. The company may have implemented cost-saving measures, negotiated better terms with suppliers, or increased the selling price of its products.
The consistent improvement in the gross profit margin suggests that ADMA Biologics Inc has been able to enhance its financial performance and generate more revenues relative to its production costs. This trend is favorable for the company's overall profitability and financial health, indicating a positive trajectory for the business.
Peer comparison
Dec 31, 2023